Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies von Lim, Sun Min, Syn, Nicholas L., Cho, Byoung Chul, Soo, Ross A.

Volltext

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer von Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M, Felip, Enriqueta, Martini, Jean-François

Volltext

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial von Shaw, Alice T, Solomon, Benjamin J, Chiari, Rita, Riely, Gregory J, Besse, Benjamin, Soo, Ross A, Kao, Steven, Lin, Chia-Chi, Bauer, Todd M, Clancy, Jill S, Thurm, Holger, Martini, Jean-Francois, Peltz, Gerson, Abbattista, Antonello, Li, Sherry, Ou, Sai-Hong Ignatius

Volltext

De-novo and acquired resistance to immune checkpoint targeting von Syn, Nicholas L, Teng, Michele W L, Mok, Tony S K, Soo, Ross A

Volltext

Can therapeutic drug monitoring of lorlatinib help us design the right CROWN? von Li, Molly, Soo, Ross A.

Volltext

Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells von Khoo, Bee Luan, Warkiani, Majid Ebrahimi, Tan, Daniel Shao-Weng, Bhagat, Ali Asgar S, Irwin, Darryl, Lau, Dawn Pingxi, Lim, Alvin S T, Lim, Kiat Hon, Krisna, Sai Sakktee, Lim, Wan-Teck, Yap, Yoon Sim, Lee, Soo Chin, Soo, Ross A, Han, Jongyoon, Lim, Chwee Teck

Volltext

Third generation EGFR TKIs: current data and future directions von Tan, Chee-Seng, Kumarakulasinghe, Nesaretnam Barr, Huang, Yi-Qing, Ang, Yvonne Li En, Choo, Joan Rou-En, Goh, Boon-Cher, Soo, Ross A

Volltext

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study von Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Felip, Enriqueta, Soo, Ross A, Camidge, D Ross, Chiari, Rita, Bearz, Alessandra, Lin, Chia-Chi, Gadgeel, Shirish M, Riely, Gregory J, Tan, Eng Huat, Seto, Takashi, James, Leonard P, Clancy, Jill S, Abbattista, Antonello, Martini, Jean-François, Chen, Joseph, Peltz, Gerson, Thurm, Holger, Ou, Sai-Hong Ignatius, Shaw, Alice T

Volltext

Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer von Tan, Chee-Seng, Cho, Byoung-Chul, Soo, Ross A

Volltext

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions von Soo, Ross A., Lim, Sun Min, Syn, Nicholas L., Teng, Rebecca, Soong, Richie, Mok, Tony S.K., Cho, Byoung Chul

Volltext

Isolation and retrieval of circulating tumor cells using centrifugal forces von Hou, Han Wei, Warkiani, Majid Ebrahimi, Khoo, Bee Luan, Li, Zi Rui, Soo, Ross A., Tan, Daniel Shao-Weng, Lim, Wan-Teck, Han, Jongyoon, Bhagat, Ali Asgar S., Lim, Chwee Teck

Volltext

Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies von Walsh, Robert J., Soo, Ross A.

Volltext

“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy von Torlakovic, Emina, Lim, Hyun J., Adam, Julien, Barnes, Penny, Bigras, Gilbert, Chan, Anthony W. H., Cheung, Carol C., Chung, Jin-Haeng, Couture, Christian, Fiset, Pierre O., Fujimoto, Daichi, Han, Gang, Hirsch, Fred R., Ilie, Marius, Ionescu, Diana, Li, Chao, Munari, Enrico, Okuda, Katsuhiro, Ratcliffe, Marianne J., Rimm, David L., Ross, Catherine, Røge, Rasmus, Scheel, Andreas H., Soo, Ross A., Swanson, Paul E., Tretiakova, Maria, To, Ka F., Vainer, Gilad W., Wang, Hangjun, Xu, Zhaolin, Zielinski, Dirk, Tsao, Ming-Sound

Volltext

An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells von Warkiani, Majid Ebrahimi, Khoo, Bee Luan, Tan, Daniel Shao-Weng, Bhagat, Ali Asgar S, Lim, Wan-Teck, Yap, Yoon Sim, Lee, Soo Chin, Soo, Ross A, Han, Jongyoon, Lim, Chwee Teck

Volltext

The promise of bispecific antibodies: Clinical applications and challenges von Lim, Sun Min, Pyo, Kyoung-Ho, Soo, Ross A, Cho, Byoung Chul

Volltext

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study von Schuler, Martin, Cho, Byoung Chul, Sayehli, Cyrus Michael, Navarro, Alejandro, Soo, Ross A, Richly, Heike, Cassier, Philippe Alexandre, Tai, David, Penel, Nicolas, Nogova, Lucia, Park, Se Hoon, Schostak, Martin, Gajate, Pablo, Cathomas, Richard, Rajagopalan, Prabhu, Grevel, Joachim, Bender, Sebastian, Boix, Oliver, Nogai, Hendrik, Ocker, Matthias, Ellinghaus, Peter, Joerger, Markus

Volltext

Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC) von Barr Kumarakulasinghe, Nesaretnam, Zanwijk, Nico van, Soo, Ross A.

Volltext

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer von Ali, Azhar, Levantini, Elena, Teo, Jun Ting, Goggi, Julian, Clohessy, John G, Wu, Chan Shuo, Chen, Leilei, Yang, Henry, Krishnan, Indira, Kocher, Olivier, Zhang, Junyan, Soo, Ross A, Bhakoo, Kishore, Chin, Tan Min, Tenen, Daniel G

Volltext

Nivolumab in NSCLC: latest evidence and clinical potential von Sundar, Raghav, Cho, Byoung-Chul, Brahmer, Julie R., Soo, Ross A.

Volltext

Immunotherapy in the treatment of non-small cell lung cancer von Sundar, Raghav, Soong, Richie, Cho, Byoung-Chul, Brahmer, Julie R, Soo, Ross A

Volltext